Viromed Medical AG Market Cap ($449.86 Million)
Market Cap & Net Worth: Viromed Medical AG (Q11)
Viromed Medical AG market cap. Viromed Medical AG (DU:Q11) has a market capitalization of $449.86 Million (€384.79 Million) as of November 4, 2026. Listed on the DU stock exchange, this Germany-based company holds position #12493 globally and #1355 in its home market, demonstrating a -5.23% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Viromed Medical AG's stock price €7.25 by its total outstanding shares 454107008 (454.11 Million). Also see Viromed Medical AG cash conversion from operations for how efficiently the company converts equity into cash flow.
Viromed Medical AG Market Cap History (2023–2026)
Viromed Medical AG market cap history from 2023 to 2026. Data shows change from $2.12 Billion to $2.55 Billion (-1.36% CAGR). Check Viromed Medical AG stock quote for real-time trading data and today's change.
Viromed Medical AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Viromed Medical AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Viromed Medical AG to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of Q11 by Market Capitalization
Companies near Viromed Medical AG in the global market cap rankings as of November 4, 2026. Also see Q11 total asset value for a full breakdown of the balance sheet.
Key companies related to Viromed Medical AG by market ranking:
- Newmont Corporation (AU:NEM): Ranked #212 globally with a market cap of $115.19 Billion USD ( AU$162.80 Billion AUD).
- Newmont Goldcorp Corp (NYSE:NEM): Ranked #213 globally with a market cap of $114.95 Billion USD.
- Agnico Eagle Mines Limited (TO:AEM): Ranked #309 globally with a market cap of $87.33 Billion USD ( CA$120.72 Billion CAD).
- Zijin Mining Group Co Ltd Class A (SHG:601899): Ranked #336 globally with a market cap of $80.91 Billion USD ( CN¥552.93 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #212 | Newmont Corporation | AU:NEM | $115.19 Billion | AU$152.50 |
| #213 | Newmont Goldcorp Corp | NYSE:NEM | $114.95 Billion | $109.09 |
| #309 | Agnico Eagle Mines Limited | TO:AEM | $87.33 Billion | CA$238.41 |
| #336 | Zijin Mining Group Co Ltd Class A | SHG:601899 | $80.91 Billion | CN¥26.84 |
Market Capitalization of Viromed Medical AG (2023–2026)
Market capitalization of Viromed Medical AG from 2023 to today. Between 2023 and today, Viromed Medical AG's market cap moved from $2.12 Billion to $ 2.55 Billion, with a yearly change of -1.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €2.55 Billion | +32.60% |
| 2025 | €1.92 Billion | +44.80% |
| 2024 | €1.33 Billion | -37.50% |
| 2023 | €2.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 15th, 2026 the market cap of Viromed Medical AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $449.86 Million USD |
| MoneyControl | $449.86 Million USD |
| MarketWatch | $449.86 Million USD |
| marketcap.company | $449.86 Million USD |
| Reuters | $449.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Viromed Medical AG
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.